Leadership Overview
Unilab has 8 executives leading key functions including strategy, operations, information technology, finance, legal, and health services.
Driven by a commitment to health and wellness, Unilab manufactures pharmaceuticals and related products, impacting lives across the Philippines and beyond with its dedication to quality and accessibility.
Driven by a commitment to health and wellness, Unilab manufactures pharmaceuticals and related products, impacting lives across the Philippines and beyond with its dedication to quality and accessibility.
Leadership Roles at Unilab
Ralph Gray - Chief Executive Officer
Ralph Gray, the Chief Executive Officer at Unilab, directs the overarching corporate strategy and operational execution. Gray's leadership ensures alignment with Unilab's mission to provide accessible healthcare solutions. This involves guiding the company's expansion into new markets and optimizing existing product lines. Gray oversees the integration of research and development initiatives with manufacturing processes to maintain product quality and innovation. The Chief Executive Officer's role requires close collaboration with other senior leaders to drive financial performance and long-term sustainability. Gray's strategic vision shapes Unilab's response to evolving industry trends and regulatory landscapes, ensuring the company remains a leader in the pharmaceutical sector. By fostering a culture of excellence, Gray empowers teams to achieve ambitious goals and deliver exceptional value to patients and stakeholders.
Sebastian Baquiran - President & Chief Executive Officer
Sebastian Baquiran, the President & Chief Executive Officer at Unilab, spearheads the company's strategic direction and operational management. Baquiran's leadership focuses on driving growth and innovation within the pharmaceutical manufacturing sector. This involves overseeing all major business units and ensuring cohesive execution of corporate objectives. The President & Chief Executive Officer's responsibilities include fostering key partnerships and expanding Unilab's market presence. Baquiran directs efforts to enhance operational efficiency and maintain the highest standards of product quality. By championing strategic initiatives, Sebastian Baquiran ensures Unilab effectively addresses the healthcare needs of its target populations. This executive role demands a comprehensive understanding of market dynamics and a proactive approach to business development, positioning Unilab for sustained success.
Luis Vaca - Chief Financial Officer
Luis Vaca, the Chief Financial Officer at Unilab, directs all financial planning, management, and reporting activities. Vaca's leadership ensures the fiscal health and strategic allocation of resources for the company's pharmaceutical operations. This includes overseeing budgeting, forecasting, and investment strategies to support Unilab's growth objectives. The Chief Financial Officer's responsibilities encompass managing financial risks, optimizing capital structure, and ensuring compliance with financial regulations. Luis Vaca plays a pivotal role in driving profitability and shareholder value through sound financial stewardship. By providing critical financial insights, Vaca enables informed decision-making across all levels of the organization, reinforcing Unilab's commitment to sustainable business practices and market leadership.
Julio Cortes - President
Julio Cortes, the President at Unilab, drives the strategic vision and operational execution across key business segments. Cortes' leadership focuses on enhancing Unilab's market position through innovation and operational excellence in pharmaceutical manufacturing. This involves overseeing the development and implementation of growth strategies and ensuring alignment with corporate objectives. The President's responsibilities include fostering strong relationships with stakeholders and expanding Unilab's reach. Julio Cortes directs efforts to optimize supply chain management and product distribution, ensuring accessibility of healthcare solutions. By championing strategic initiatives, Cortes ensures Unilab effectively meets the evolving healthcare needs of its customers and communities.
Manolet Montinola - Group President, Ul Health Services, Unilab
Manolet Montinola, the Group President, Ul Health Services, Unilab, leads the strategic direction and operational management of Unilab's health services division. Montinola's leadership focuses on expanding the scope and impact of healthcare services offered by the company. This involves overseeing the integration of pharmaceutical products with comprehensive health solutions to meet diverse patient needs. The Group President's responsibilities include driving innovation in healthcare delivery models and ensuring high standards of patient care. Manolet Montinola plays a critical role in developing strategic partnerships that enhance Unilab's service offerings. By focusing on patient well-being and accessibility, Montinola strengthens Unilab's commitment to improving health outcomes across the regions it serves.
Francisco Ortega - Chief Information Officer
Francisco Ortega, the Chief Information Officer at Unilab, architects and manages the company's technology infrastructure and digital transformation initiatives. Ortega's leadership ensures that Unilab's IT systems support efficient operations and data security across all departments. This involves overseeing the implementation of advanced software solutions and digital platforms that enhance productivity and streamline workflows. The Chief Information Officer's role is critical in leveraging technology to improve manufacturing processes and supply chain management. Francisco Ortega drives innovation in data analytics and cybersecurity to protect sensitive information and gain competitive insights. By aligning technology strategy with business objectives, Ortega empowers Unilab to adapt to the digital age and maintain a strong market position in pharmaceutical manufacturing.
Jennifer Inocentes - Chief of Staff
Jennifer Inocentes, the Chief of Staff at Unilab, serves as a key strategic advisor and operational facilitator for the executive leadership team. Inocentes' role involves driving cross-functional initiatives and ensuring seamless execution of strategic priorities across the organization. This includes managing special projects, optimizing internal communication, and enhancing organizational efficiency. The Chief of Staff's responsibilities extend to supporting the President and CEO in day-to-day operations and long-term planning. Jennifer Inocentes facilitates effective collaboration among departments, ensuring alignment with Unilab's mission in pharmaceutical manufacturing. By streamlining processes and fostering a cohesive work environment, Inocentes contributes significantly to the company's operational excellence and strategic advancement.
Terence Lee - Chief Legal Officer
Terence Lee, the Chief Legal Officer at Unilab, oversees all legal affairs and ensures regulatory compliance for the company's pharmaceutical operations. Lee's leadership safeguards Unilab against legal risks and guides strategic decisions with sound legal counsel. This involves managing corporate governance, intellectual property, and contract negotiations. The Chief Legal Officer's responsibilities include advising on compliance with national and international pharmaceutical regulations. Terence Lee plays a crucial role in shaping Unilab's legal framework to support innovation and market expansion. By ensuring adherence to legal standards, Lee protects the company's reputation and fosters a secure operating environment, enabling Unilab to maintain its leadership in the healthcare sector.
Explore Leadership Teams in Manufacturing
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership
BK
LR
HL
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
MA

Founded in 1993 and located in Cambridge, Massachusetts, Takeda Oncology is the oncology specialty business unit of Takeda Pharmaceutical. Takeda Oncology develops and produces oncology therapies for patients around the world.
Company Leadership
TF
CB
UCB, founded in 1928 and headquartered in Brussels, Belgium, is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
Company Leadership DX
MD
SO
CD